Science & technology | Island life

Isolated communities are more at risk of rare genetic diseases

The isolation can be geographic or cultural

Aerial view of an island, Shetland Islands, Scotland.
This susceptible islePhotograph: Getty Images

ISLAND LIFE is famously idyllic, but it’s long been known that islanders tend to experience disproportionately high rates of some rare genetically transmitted diseases. Faroe islanders, for example, who live on an archipelago in the North Atlantic Ocean, have a much higher-than-average incidence of carnitine transporter deficiency (CTD), a condition that prevents the body from using certain fats for energy. Inhabitants of Gran Canaria, meanwhile, an island off the north-western coast of Africa, are far more likely than average to have familial hypercholesterolaemia, a condition where the liver cannot process cholesterol effectively.

This article appeared in the Science & technology section of the print edition under the headline “The gene-variant archipelago”

From the October 5th 2024 edition

Discover stories from this section and more in the list of contents

Explore the edition

Discover more

left: John Hopfield  right: Dr. Geoffrey Hinton.

AI researchers receive the Nobel prize for physics

The award, to Geoffrey Hinton and John Hopfield, stretches the definition of the field

Victor Ambros Molecular & Gary Ruvkun.

A Nobel prize for the discovery of micro-RNA

These tiny molecules regulate genes and control how cells develop and behave


Illustration of a yellow smiley face with a frown instead of a smile, across the frown, there’s a colorful wave that looks like an audio waveform

AI offers an intriguing new way to diagnose mental-health conditions

Models look for sound patterns undetectable by the human ear


Why it’s so hard to tell which climate policies actually work

Better tools are needed to analyse their effects

An adult fruit fly brain has been mapped—human brains could follow

For now, it is the most sophisticated connectome ever made

Immune therapy shows promise for asthma, heart disease—and even ageing

Making treatment quick and affordable will be the challenge